Business Description
Sinphar Pharmaceutical Co Ltd
ISIN : TW0001734002
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.56 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | 3.34 | |||||
Interest Coverage | 8.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.27 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 54.7 | |||||
3-Year FCF Growth Rate | 26.5 | |||||
3-Year Book Growth Rate | 4.1 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.93 | |||||
9-Day RSI | 53.47 | |||||
14-Day RSI | 54.45 | |||||
6-1 Month Momentum % | 12.84 | |||||
12-1 Month Momentum % | 13.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.2 | |||||
Quick Ratio | 1.5 | |||||
Cash Ratio | 0.9 | |||||
Days Inventory | 155.26 | |||||
Days Sales Outstanding | 61.13 | |||||
Days Payable | 56.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.73 | |||||
Dividend Payout Ratio | 0.45 | |||||
3-Year Dividend Growth Rate | 71 | |||||
Forward Dividend Yield % | 2.73 | |||||
5-Year Yield-on-Cost % | 11.62 | |||||
Shareholder Yield % | 6.28 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.83 | |||||
Operating Margin % | 9.71 | |||||
Net Margin % | 12.66 | |||||
FCF Margin % | -0.15 | |||||
ROE % | 12.51 | |||||
ROA % | 6.14 | |||||
ROIC % | 7.75 | |||||
ROC (Joel Greenblatt) % | 8.98 | |||||
ROCE % | 7.02 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.44 | |||||
PE Ratio without NRI | 16.38 | |||||
Shiller PE Ratio | 70.2 | |||||
Price-to-Owner-Earnings | 19.08 | |||||
PEG Ratio | 0.55 | |||||
PS Ratio | 2.07 | |||||
PB Ratio | 1.97 | |||||
Price-to-Tangible-Book | 2.03 | |||||
Price-to-Operating-Cash-Flow | 20.79 | |||||
EV-to-EBIT | 20.65 | |||||
EV-to-EBITDA | 12.02 | |||||
EV-to-Revenue | 2.35 | |||||
EV-to-FCF | -1500.56 | |||||
Price-to-Projected-FCF | 2.81 | |||||
Price-to-Median-PS-Value | 1.09 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.66 | |||||
Price-to-Graham-Number | 1.22 | |||||
Earnings Yield (Greenblatt) % | 4.83 | |||||
FCF Yield % | -0.08 | |||||
Forward Rate of Return (Yacktman) % | 19.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sinphar Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 2,962.934 | ||
EPS (TTM) (NT$) | 2.23 | ||
Beta | 0.12 | ||
Volatility % | 16.18 | ||
14-Day RSI | 54.45 | ||
14-Day ATR (NT$) | 0.650432 | ||
20-Day SMA (NT$) | 36.66 | ||
12-1 Month Momentum % | 13.92 | ||
52-Week Range (NT$) | 31.1 - 41.1 | ||
Shares Outstanding (Mil) | 167.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sinphar Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sinphar Pharmaceutical Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Sinphar Pharmaceutical Co Ltd Frequently Asked Questions
What is Sinphar Pharmaceutical Co Ltd(TPE:1734)'s stock price today?
When is next earnings date of Sinphar Pharmaceutical Co Ltd(TPE:1734)?
Does Sinphar Pharmaceutical Co Ltd(TPE:1734) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |